What entity is primarily responsible for investigating allegations of research misconduct: the Office of Research Integrity (ORI), researcher(s), or research institution(s)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The primary responsibility for investigating allegations of research misconduct belongs to the research institution(s). The correct answer is C. Research institution(s). This is based on the principle that oversight of the ethical conduct of human research includes activities by the primary investigators, the agencies or groups that sponsor the research, the local IRB, and the Office of Human Research Protection (OHRP) in the Department of Health and Human Services 1. When allegations of research misconduct arise, the institution is required to initiate an inquiry, conduct a thorough investigation if warranted, and take appropriate actions based on their findings. Some key points to consider include:

  • The institution has established policies and procedures specifically designed to address research misconduct allegations, including committees and administrative structures to ensure fair and thorough investigations while protecting both the integrity of the research process and the rights of all parties involved.
  • While the Office of Research Integrity (ORI) provides oversight and guidance for research misconduct proceedings in federally funded research, it does not conduct the initial investigations itself 1.
  • Similarly, while individual researchers have ethical obligations to report suspected misconduct, they are not primarily responsible for conducting formal investigations.
  • The OHRP has the authority to regulate IRB activities and make sure that institutions comply with the federal regulations on human subject research, and it also is empowered to serve as a liaison with various commissions and agencies to examine ethical issues in medicine and to promote the development of methods to improve the quality of programs for protection of participants in research 1.

From the Research

Primary Responsibility for Investigating Allegations of Research Misconduct

  • The primary responsibility for investigating allegations of research misconduct belongs to research institutions, as they have the most direct involvement with the researchers and the research being conducted 2.
  • The Office of Research Integrity (ORI) also plays a role in handling allegations of research misconduct, but its primary function is to oversee and coordinate the efforts of research institutions, rather than to conduct investigations itself 2.
  • Researchers themselves may also be involved in the investigation process, but they are not typically responsible for conducting the investigation or making determinations about misconduct.

Relevant Options

  • Option C (Research institution(s)) is the most accurate answer, as research institutions have the primary responsibility for investigating allegations of research misconduct.
  • Option D (B and C) is also a possible answer, as researchers may be involved in the investigation process, but it is not the most accurate answer.
  • Options A (Office of Research Integrity (ORI)), B (Researcher(s)), and E (A, B and C) are not the most accurate answers, as while they may play a role in the process, they are not the primary responsible parties.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Complainant issues in research misconduct: the office of research integrity experience.

Experimental biology and medicine (Maywood, N.J.), 2006

Related Questions

In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
Must every aspect of a research study be documented in compliance with Good Clinical Practice (GCP) guidelines to obtain useful data?
Is C15 (Compound 15) safe and effective for use in humans?
Is it recommended to admit a patient to a nursing home without a prior medical evaluation by a receiving physician (General Practitioner)?
What is the cause of paresthesia (tingling sensation) and numbness in a 31-year-old female with a history of recurrent pregnancy losses secondary to endometriosis, who is currently on birth control and was weaned off hormone therapy (hormone replacement therapy) due to In Vitro Fertilization (IVF)?
What is the treatment for acute lumbar radiculopathy (lumbago) with sciatica?
Do researchers and research institutions have the primary responsibility for reporting and investigating allegations of research misconduct, specifically regarding Good Clinical Practice (GCP)?
What is the treatment for acute diverticulitis?
What is the correction for hypernatremia (elevated sodium levels)?
What are the treatment options for non-plaque psoriasis subtypes, including guttate, inverse, pustular, and erythrodermic psoriasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.